Clovis Oncology (Biopharma) — Funding, Investors & Signals 2026

Clovis Oncology

Founded 2009

Boulder, United States 70 employees Series Unknown Total: $145.00M Biopharma

Clovis Oncology, a commercial-stage biotechnology company founded in 2009, is dedicated to advancing the fight against cancer. The company's focus on acquiring, developing, and commercializing cancer treatments in the United States, Europe, and other international markets demonstrates its commitment to improving the lives of cancer patients. The core of Clovis Oncology's approach lies in precision medicine, aiming to deliver the right drug to the right patient at the right time, thus shaping the future of cancer therapy. Their product development programs target specific subsets of cancer, and they collaborate with partners to develop diagnostic tools intended to direct a compound to the patients most likely to benefit. This approach underscores their commitment to personalized treatment solutions. With its management team's extensive experience in developing novel cancer therapies, Clovis Oncology is well-positioned to make meaningful improvements in patients' lives. Headquartered in Boulder, Colorado, Clovis Oncology's most recent Venture Round investment was on 02 June 2011, with Pfizer Venture Investments as the investor. This signifies a vote of confidence from a prominent investor in the company's vision and potential within the biopharma industry. For more information about Clovis Oncology and its activities, interested individuals can refer to the company's official website.

Funding Stage	Amount	Investors	Lead Investors	Date
Venture Round	••••••	1	•••• ••••	02 Jun 2011
Venture Round	••••••	7		21 May 2009

Funding Stage

Amount

Investors

Lead Investors

Date

Venture Round

••••••

•••• ••••

02 Jun 2011

Venture Round

••••••

21 May 2009

FAQ About Clovis Oncology

Clovis Oncology is advancing the fight against cancer. Founded in 2009, Clovis Oncology is a commercial-stage biotechnology company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Our pursuit is to improve the live...

Clovis Oncology was founded in 2009.

Clovis Oncology is headquartered in Boulder, United States.

Clovis Oncology operates in the following industries: Biopharma.

Clovis Oncology has approximately 70 employees.

Clovis Oncology has completed 2 funding rounds, raising a total of $145.00M. The latest funding stage is Series Unknown.

Top alternatives and competitors to Clovis Oncology include OnQuality Pharmaceuticals Ltd., Sunesis Pharmaceuticals, Inc., Shorla Oncology, Novocure, Athenex. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Clovis Oncology and OnQuality Pharmaceuticals Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Clovis Oncology

General Information

Track Clovis Oncology

Discover More

About Clovis Oncology

Funding Rounds & Investors (2)

Clovis Oncology Alternatives & Competitors

FAQ About Clovis Oncology

Don't just browse. Track.